News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In
Digital Pathology Implementation Strategies

Digital Pathology Implementation Strategies

digital pathology webinar

As reimbursement for digital pathology services starts to potentially become a reality, more hospital, clinical laboratory, and reference lab leaders will explore the technology.

Do you know where to start with implementing a digital pathology program for your hospital, health system, or independent pathology group to make the best use of your budget? “Digital Pathology Implementation Strategies,hosted by Dark Daily and sponsored by Hamamatsu, aired May 10, 2023, and is now available for free streaming.

Pathologists, hospital executives, and lab leaders need help cutting through frequently published news and commentary about digital pathology. They will find this new webinar practical and incisive for gaining a foothold on what to do for digital pathology should regulatory and reimbursement decisions rapidly evolve in favor of greater digital pathology adoption in the U.S.

Pathology is in a time of rapid change. Use this free, 60-minute Dark Daily webinar as a practical update and an essential tool.

Meet the Experts

Dean Wallace, MD, Professor of Pathology, Keck School of Medicine W. Dean Wallace, MD, is a Professor of Pathology at the Keck School of Medicine at University of Southern California (USC). Dr. Wallace’s ongoing work in informatics and digital pathology includes collaborative efforts in radiology and pathology correlation and implementation of digital pathology into standard pathology practice workflows. Other areas of research include creation of novel pathology staining techniques using machine learning technology.

Orly Ardon, PhD, MBA, Memorial Sloan Kettering Cancer Center Orly Ardon, PhD, MBA, is the Director of Digital Pathology Operations at Memorial Sloan Kettering Cancer Center’s Pathology Department and the Scientific Operations Investigator at the Warren Alpert Center for Digital and Computational Pathology. Dr. Ardon is leading the digital scanning team and operations of the different scanning initiatives and collaborations at MSKCC. Her research interests include digital pathology technologies, laboratory process improvements, and healthcare economics.

Key Learnings

• Understand key workflow aspects of the components needed in a digital pathology service
• Gain an understanding of common limitations of commercial digital pathology products
• Clarify how to structure your digital pathology implementation team
• Learn a goal-based approach to develop your business case for digital pathology implementation in hospitals, health systems, and independent pathology groups

Sponsored by

Digital Pathology Implementation
Virus Surveillance: Empowering Communities Through Early Genotypic Testing for HIV Drug Resistance

Virus Surveillance: Empowering Communities Through Early Genotypic Testing for HIV Drug Resistance

Dark Daily White Paper HIV Drug Resistance Testing

Dark Daily’s free white paper, “Virus Surveillance: Empowering Communities Through Early Genotypic Testing for HIV Drug Resistance,” addresses several facets of HIV surveillance, including genotypic testing for drug-resistant mutations, virus cluster detection and response, and programs in action. The new white paper for the health laboratory community has been produced in partnership with Thermo Fisher Scientific and is available for free download.

As antiretroviral drugs are a primary HIV therapy, the World Health Organization (WHO) warns that all antiretrovirals, including those from newer drug classes, are at risk of becoming partially or fully inactive due to the emergence of drug-resistant virus—it’s just a matter of time. This is an important point because if not prevented, HIV drug resistance can jeopardize the efficacy of medicines used to treat HIV, resulting in increased numbers of HIV infections, HIV-associated morbidity and mortality, and the need to develop new antiretrovirals.

Health laboratory directors interested in reducing the impact of emerging and harmful HIV drug-resistant mutations can use this white paper educational supplement for a new look at:

  • Care gaps in viral load monitoring and drug resistance testing;
  • Recent developments signaling new paths forward with HIV-1 testing; and
  • Programs that monitor genetic evolution of drug-resistant mutations for people living with HIV.

This report specifically addresses drug-resistance testing needs, policy decisions influencing HIV testing, and insights from virus surveillance, cluster detection and response efforts. The white paper also includes a reference resource list.

Click here to download the free white paper. For additional information inquire at info@darkreport.com, or call Amanda Curtis at 512-264-7103.

Published March 27, 2023
Produced in partnership with

Dark Daily White Paper HIV Drug Resistance Testing
;